Related Articles
Plasminogen activator inhibitor-1 in kidney pathology (Review)
Plasminogen activation system in oral cancer: Relevance in prognosis and therapy (Review)
Can inactivators of plasminogen activator inhibitor alleviate the burden of obesity and diabetes? (Review)
Theaflavin digallate inactivates plasminogen activator inhibitor: Could tea help in Alzheimer's disease and obesity?
Systemic or topical application of plasminogen activator inhibitor with extended half-life (VLHL PAI-1) reduces bleeding time and total blood loss